STAT2 and neoplasm: We find that high expression and T404 phosphorylation of STAT2 inhibit STING subcellular translocation and reduce the production of IRF3-dependent cytokines, including IFNs and T cell chemotaxis, without inhibiting IL-6 production, thus promoting tumor cell survival.